Cytek Biosciences Inc expected to post earnings of 3  cents a share - Earnings Preview

Cytek Biosciences

05/08/2023 02:31

* Cytek Biosciences Inc  CTKB.OQ   CTKB.O  is expected
to show a
rise in quarterly revenue when it reports  results on August 8. 
    * The Fremont California-based  company is expected to
report  a
13.8% increase in revenue to $45.713 million from $40.16 million
a year ago, according to the mean estimate from 4 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Cytek Biosciences
Inc is
for earnings of 3 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Cytek
Biosciences
Inc is $14​, above​ its last closing price of $9.09. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2023  0.03        0.03       0.00      Missed  -100
 Dec. 31 2023  0.05        0.05       0.06      Beat    28.6
 Sep. 30 2022  0.02        0.02       0.04      Beat    100​
 Jun. 30 2022  0.03        0.02       0.03      Beat    80
 ​​Mar.        -0.01       0.00       0.01      Beat    300
 31 2022                                                
 Dec. 31 2021  0.02        0.03       0.03      Met     20​
 Sep. 30 2021  0.03        0.02       0.02      Met     -14.3
 Jun. 30 2021  0.02        0.02       0.00      Missed  -100
 This summary was machine generated August 5 at 01:31 GMT.  All
figures in US dollars  unless otherwise stated